The long term effect of current and new interventions on the new case detection of leprosy: A modeling study

PLoS Neglected Tropical Diseases

Volumn 5, Issue 9, 2011, Pages

  Fischer, Egil A J ^a,b   de Vlas, Sake J ^a   Habbema, J Dik F ^a   Richardus, Jan Hendrik ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ANTIINFECTIVE AGENT;

ARTICLE; CASE STUDY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG TREATMENT FAILURE; EARLY DIAGNOSIS; HUMAN; INTERVENTION STUDY; LEPROSY; MICROSIMULATION MODEL; PREDICTION; SIMULATION; TREND STUDY; ADULT; CHILD; COMPUTER SIMULATION; CONTACT EXAMINATION; FEMALE; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; MYCOBACTERIUM LEPRAE; NEWBORN; PRESCHOOL CHILD;

ADULT; ANTI-BACTERIAL AGENTS; BCG VACCINE; CHEMOPREVENTION; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; CONTACT TRACING; EARLY DIAGNOSIS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INTERVENTION STUDIES; LEPROSY; MALE; MYCOBACTERIUM LEPRAE;

EID: 80053447671     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001330     Document Type: Article

References (22)

1. Anonymous, (2009) Global leprosy situation, 2009. Wkly Epidemiol Rec 84: 333-340.
2. Moet FJ, Pahan D, Oskam L, Richardus JH, (2008) Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial. Bmj 336: 761-764.
3. Reveiz L, Buendia JA, Tellez D, (2009) Chemoprophylaxis in contacts of patients with leprosy: systematic review and meta-analysis. Rev Panam Salud Publica 26: 341-349.
4. Geluk A, Spencer JS, Bobosha K, Pessolani MC, Pereira GM, et al. (2009) From genome-based in silico predictions to ex vivo verification of leprosy diagnosis. Clin Vaccine Immunol 16: 352-359.
5. Merle CS, Cunha SS, Rodrigues LC, (2010) BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control. Expert Rev Vaccines 9: 209-222.
6. Kaufmann SH, Hussey G, Lambert PH, (2010) New vaccines for tuberculosis. Lancet 375: 2110-2119.
7. Brennan MJ, Fruth U, Milstien J, Tiernan R, de Andrade Nishioka S, et al. (2007) Development of new tuberculosis vaccines: a global perspective on regulatory issues. PLoS Med 4: e252.
8. Richardus JH, Saunderson P, Smith C, (2011) Will new tuberculosis vaccines provide protection against leprosy? Int J Tuberc Lung Dis 15: 143.
9. Fischer E, De Vlas S, Meima A, Habbema D, Richardus J, (2010) Different mechanisms for heterogeneity in leprosy susceptibility can explain disease clustering within households. PLoS One 5: e14061.
10. Moet FJ, Oskam L, Faber R, Pahan D, Richardus JH, (2004) A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP. Lepr Rev 75: 376-388.
11. Moet FJ, Pahan D, Schuring RP, Oskam L, Richardus JH, (2006) Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy. J Infect Dis 193: 346-353.
12. Fischer E, Pahan D, Chowdhury S, Oskam L, Richardus J, (2008) The spatial distribution of leprosy in four villages in Bangladesh: an observational study. BMC Infect Dis 8: 125.
13. Moet FJ, Schuring RP, Pahan D, Oskam L, Richardus JH, (2008) The prevalence of previously undiagnosed leprosy in the general population of northwest bangladesh. PLoS Negl Trop Dis 2: e198.
14. Fine PE, (1982) Leprosy: the epidemiology of a slow bacterium. Epidemiol Rev 4: 161-188.
15. Noordeen S, (1985) The epidemiology of leprosy. In: Hastings R, editors. Leprosy Edinburgh Churchill Livingstone.
16. Meima A, Smith WC, van Oortmarssen GJ, Richardus JH, Habbema JD, (2004) The future incidence of leprosy: a scenario analysis. Bull World Health Organ 82: 373-380.
17. Anonymous, (2007) WHO/UNICEF review of national immunization coverage, 1980-2006. Geneva World Health Organization.
18. Setia MS, Steinmaus C, Ho CS, Rutherford GW, (2006) The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis 6: 162-170.
19. Schuring RP, Moet FJ, Pahan D, Richardus JH, Oskam L, (2006) Association between anti-pGL-I IgM and clinical and demographic parameters in leprosy. Lepr Rev 77: 343-355.
20. Gillis T, Vissa V, Matsuoka M, Young S, Richardus JH, et al. (2009) Characterisation of short tandem repeats for genotyping Mycobacterium leprae. Lepr Rev 80: 250-260.
21. Hall BG, Salipante SJ, (2010) Molecular epidemiology of Mycobacterium leprae as determined by structure-neighbor clustering. J Clin Microbiol 48: 1997-2008.
22. Schuring RP, Richardus JH, Pahan D, Oskam L, (2009) Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention. Vaccine 27: 7125-7128.